| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |









||||
From the Department of Obstetrics, Gynecology, and Reproductive
Sciences,*
the Cancer Research
Institute,
the Department of
Pathology
and the Department of
Medicine,
University of California at
San Francisco, San Francisco, California; the Department of
Pathology,¶
at the University of California at
San Diego, San Diego, California; Lincoln Medical and Mental Health
Center,||
New York City/Bronx Consortium,
Bronx, New York; the Department of Obstetrics and Gynecology,**
Maimonides Medical Center, Brooklyn, New York; the CORE
Center,

Chicago, Illinois; the Department of
Medicine,

Georgetown University
Medical Center, Washington, DC; the School of
Medicine,

University of Southern
California, Los Angeles County/Southern California Consortium, Los
Angeles, California; Bloomberg School of Public
Health,¶¶
the Johns Hopkins University,
Baltimore, Maryland; and the Connie Wofsy Study Consortium of Northern
California,||||
San Francisco,
California
The exact role of the mucosal immune response in the pathogenesis of human papillomavirus (HPV)-related premalignant and malignant diseases of the genital tract is poorly understood. We used immunohistochemical analysis to characterize immune cells in normal cervix (N = 21), HIV-negative high-grade dysplasia (N = 21), and HIV-positive high-grade dysplasia (N = 30). Classical germinal centers were present in 4.7% of normal cervix, 33% of high-grade lesions from HIV-negative women, and 3.3% of high-grade lesions from HIV-positive women (P = 0.003). HPV16 E7 antigen was detected in a subset of germinal centers, indicating that the secondary immune response was directed in part against HPV. Lymphoid follicles were present in 9.5% of normal cervix, 57% of HIV-negative high-grade dysplasia, and 50% of HIV-positive high-grade dysplasia (P = 0.001 normal versus high-grade). A novel type of lymphoid aggregate, consisting predominantly of CD8+ T cells, was detected in 4.8% of normal cervix, 0% of HIV-negative high-grade dysplasia, and 40% of HIV-positive high-grade dysplasia (P < 0.001). The recurrence rate of high-grade dysplasia within one year was significantly higher in women with such CD8+ T cell-dominant aggregates (P = 0.02). In summary, the types of lymphoid follicle in lesions from HIV-positive women were significantly different from those from HIV-negative women, and these differences are associated with the worse clinical outcome in HIV-positive women.
This article has been cited by other articles:
![]() |
D. Daniel, C. Chiu, E. Giraudo, M. Inoue, L. A. Mizzen, N. R. Chu, and D. Hanahan CD4+ T Cell-Mediated Antigen-Specific Immunotherapy in a Mouse Model of Cervical Cancer Cancer Res., March 1, 2005; 65(5): 2018 - 2025. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kobayashi, R. M. Greenblatt, K. Anastos, H. Minkoff, L. S. Massad, M. Young, A. M. Levine, T. M. Darragh, V. Weinberg, and K. K. Smith-McCune Functional Attributes of Mucosal Immunity in Cervical Intraepithelial Neoplasia and Effects of HIV Infection Cancer Res., September 15, 2004; 64(18): 6766 - 6774. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |